MMY KJN MEDPART Telegram | DID YOU KNOW?
Date: | MMY KJN MEDPART
At this point, however, Durov had already been working on Telegram with his brother, and further planned a mobile-first social network with an explicit focus on anti-censorship. Later in April, he told TechCrunch that he had left Russia and had “no plans to go back,” saying that the nation was currently “incompatible with internet business at the moment.” He added later that he was looking for a country that matched his libertarian ideals to base his next startup. Official government accounts have also spread fake fact checks. An official Twitter account for the Russia diplomatic mission in Geneva shared a fake debunking video claiming without evidence that "Western and Ukrainian media are creating thousands of fake news on Russia every day." The video, which has amassed almost 30,000 views, offered a "how-to" spot misinformation. Just days after Russia invaded Ukraine, Durov wrote that Telegram was "increasingly becoming a source of unverified information," and he worried about the app being used to "incite ethnic hatred." In view of this, the regulator has cautioned investors not to rely on such investment tips / advice received through social media platforms. It has also said investors should exercise utmost caution while taking investment decisions while dealing in the securities market. DFR Lab sent the image through Microsoft Azure's Face Verification program and found that it was "highly unlikely" that the person in the second photo was the same as the first woman. The fact-checker Logically AI also found the claim to be false. The woman, Olena Kurilo, was also captured in a video after the airstrike and shown to have the injuries.
MMY KJN MEDPART from de
MMY KJN MEDPART
group-telegram.com/MMYKJNMEDPART
Germany DE telegram Group & telegram Channel 10
Created:
From: Germany and Germany
Telegram MMY KJN MEDPART, 687543 Telegram Group & Telegram Channel Germany, DETelegram MMY KJN MEDPART, 687543 Telegram Group & Telegram Channel, Germany,
https://t.me/MMYKJNMEDPART
Webview